Financing - July 28, 2025
Gesynta Pharma raises SEK 347 million
The company has raised an additional SEK 43 million in its Series B second closing, bringing the total Series B capital to SEK 347 million.
Biotech Business - July 17, 2025
Abera Bioscience carries out directed issue of units
The Board of Directors has resolved, based on the authorization from the Annual General Meeting held on 11 June 2025, to carry out a directed issue of up to 1,092,480 units.
Biotech Business - July 2, 2025
Pixelgen awarded USD 14.7 million in blended funding
The company has been awarded grant and equity financing from the European Innovation Council (EIC) Accelerator, a funding initiative under the European Union's Horizon Europe program designed to support highly innovative start-ups with disruptive technologies.
Biotech Business - June 25, 2025
Qlucore receives approval for EUR 0.5 million installment from the EU
The aim of the project is to accelerate the development of clinical cancer diagnostics solutions for acute myeloid leukemia (AML) as well as bladder cancer.
Biotech Business - June 24, 2025
Cereno Scientific secures SEK 100 million
Cereno Scientific has announced entering loan financing agreements.
Biotech Business - June 5, 2025
Alvotech completes SEK 750 million private placement
The transaction attracted interest from institutional investors, with a clear majority allocated to Swedish and other international investors outside of Iceland.
